A Rapid, Cost-Effective Pre-Clinical Method to Screen for Pro- or Antiarrhythmic Effects of Substances in an Isolated Heart Preparation

Por Borg, John Joseph
Publicado no Sci Pharm (2015)

Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJ

Por Borg, John Joseph, Laslop, Andrea, Pani, Luca, Maciulaitis, Romaldas, Melchiorri, Daniela
Publicado no Sci Pharm (2014)

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective

Por Refalo, Nathaniel, Chetcuti, Daniel, Tanti, Amy, Serracino-Inglott, Anthony, Borg, John Joseph
Publicado no Saudi Pharm J (2017)

Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective

Por Borg, John Joseph, Tomasi, Paolo, Pani, Luca, Aislaitner, George, Pirozynski, Michal, Leufkens, Hubert, Melchiorri, Daniela
Publicado no Sci Pharm (2014)

European Union pharmacovigilance capabilities: potential for the new legislation

Por Borg, John Joseph, Tanti, Amy, Kouvelas, Dimitrios, Lungu, Calin, Pirozynski, Michal, Serracino-Inglott, Anthony, Aislaitner, George
Publicado no Ther Adv Drug Saf (2015)